OTIC - オトノミ― (Otonomy Inc.)

OTICのニュース

   Otitis Drug Market Analysis by Sanofi, Bristol-Myers Squibb Company, Otonomy Inc., Torrent Pharmaceuticals Ltd  2020/11/11 18:29:20 OpenPR
Otitis Drug Market By Type (Acute Otitis Media, Otitis Media with Effusion and Chronic Otitis Media with Effusion), Treatment Type (Medication and Surgery), Mechanism of Action Types (Corticosteroid, Topoisomerase Enzymes Type II Inhibitor, Cephalosporin Antibiotic and Anti-Infective), Route of Administration (Oral,
   Global Meniere's Disease Drug Market to Register Substantial Global Expansion by 2027, Get Understanding of COVID 19 effect on Industry: Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical  2020/11/06 15:05:35 OpenPR
Global Meniere's Disease Drug Market research report has been produced with the systematic gathering of market information for industry. All this information is supplied in such a way that it properly gives explanation of various facts and figures to the
   Otonomy, Inc. (NASDAQ:OTIC) Given Consensus Recommendation of “Buy” by Brokerages  2020/10/24 14:07:00 The Olympia Report
Otonomy, Inc. (NASDAQ:OTIC) has earned a consensus rating of “Buy” from the six brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on […]
   Booming Growth of Vertigo Drugs Market to Witness a Pronounce Growth at CAGR during 2020-2027| Auris Medical , Otonomy , Sensorion , Sound Pharmaceuticals  2020/10/15 10:18:37 OpenPR
The global analysis of Vertigo Drugs Market and its upcoming prospects have recently added by HealthCare Intelligence Markets to its extensive repository. It has been employed through the primary and secondary research methodologies. This market is expected to become competitive
   Global Meniere’s disease drug Market 2020-2026 Refreshing Trends || Major Giants – Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical  2020/09/28 19:11:42 OpenPR
This Global Meniere’s disease drug Market research report is a sure solution to get market insights with which you can visualize market place clearly and thereby take important decisions for growth of your business. By getting an inspiration from the
   Otitis Drug Market Analysis by Sanofi, Bristol-Myers Squibb Company, Otonomy Inc., Torrent Pharmaceuticals Ltd  2020/11/11 18:29:20 OpenPR
Otitis Drug Market By Type (Acute Otitis Media, Otitis Media with Effusion and Chronic Otitis Media with Effusion), Treatment Type (Medication and Surgery), Mechanism of Action Types (Corticosteroid, Topoisomerase Enzymes Type II Inhibitor, Cephalosporin Antibiotic and Anti-Infective), Route of Administration (Oral,
   Global Meniere's Disease Drug Market to Register Substantial Global Expansion by 2027, Get Understanding of COVID 19 effect on Industry: Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical  2020/11/06 15:05:35 OpenPR
Global Meniere's Disease Drug Market research report has been produced with the systematic gathering of market information for industry. All this information is supplied in such a way that it properly gives explanation of various facts and figures to the
   Otonomy, Inc. (NASDAQ:OTIC) Given Consensus Recommendation of “Buy” by Brokerages  2020/10/24 14:07:00 The Olympia Report
Otonomy, Inc. (NASDAQ:OTIC) has earned a consensus rating of “Buy” from the six brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on […]
   Booming Growth of Vertigo Drugs Market to Witness a Pronounce Growth at CAGR during 2020-2027| Auris Medical , Otonomy , Sensorion , Sound Pharmaceuticals  2020/10/15 10:18:37 OpenPR
The global analysis of Vertigo Drugs Market and its upcoming prospects have recently added by HealthCare Intelligence Markets to its extensive repository. It has been employed through the primary and secondary research methodologies. This market is expected to become competitive
   Global Meniere’s disease drug Market 2020-2026 Refreshing Trends || Major Giants – Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical  2020/09/28 19:11:42 OpenPR
This Global Meniere’s disease drug Market research report is a sure solution to get market insights with which you can visualize market place clearly and thereby take important decisions for growth of your business. By getting an inspiration from the
   Booming Growth of Vertigo Drugs Market to Witness a Pronounce Growth at CAGR during 2020-2027| Auris Medical , Otonomy , Sensorion , Sound Pharmaceuticals  2020/10/15 10:18:37 OpenPR
The global analysis of Vertigo Drugs Market and its upcoming prospects have recently added by HealthCare Intelligence Markets to its extensive repository. It has been employed through the primary and secondary research methodologies. This market is expected to become competitive
   Global Meniere’s disease drug Market 2020-2026 Refreshing Trends || Major Giants – Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical  2020/09/28 19:11:42 OpenPR
This Global Meniere’s disease drug Market research report is a sure solution to get market insights with which you can visualize market place clearly and thereby take important decisions for growth of your business. By getting an inspiration from the
   The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs  2020/08/19 11:32:33 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) DarioHealth Corp (NASDAQ: DRIO ) iTeos Therapeutics Inc (NASDAQ: ITOS ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Natera Inc (NASDAQ: NTRA ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Otonomy Inc (NASDAQ: OTIC ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Pacira Biosciences Inc (NASDAQ: PCRX ) PDL BioPharma Inc (NASDAQ: PDLI ) Principia Biopharma Inc (NASDAQ: PRNB ) Qiagen NV (NYSE: QGEN ) Shockwave Medical Inc (NASDAQ: SWAV ) Silk Road Medical Inc (NASDAQ: SILK ) Syros Pharmaceuticals Inc (NASDAQ: SYRS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 18) Acorda Therapeutics Inc (NASDAQ: ACOR ) Alector Inc (NASDAQ: ALEC ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Interpace Biosciences Inc (NASDAQ: IDXG )(announced receipt of letters from recently departed employees regarding billing and compliance issues) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Poseida Therapeutics, Inc. (NASDAQ: PSTX )( announced clinical hold on its Phase 1 prostate cancer study) Predictive Oncology Inc (NASDAQ: POAI ) Recro Pharma Inc (NASDAQ: REPH ) Unity Biotechnology Inc (NASDAQ: UBX ) Stocks In Focus Venrock Reports Purchase of 451K Unum Shares Unum Therapeutics Inc (NASDAQ: UMRX ) shares advanced after Venrock Healthcare Partners III L.P. said in a filing it has purchased 451,000 shares of Unum's common stock in a series of transactions effected between Aug. 14 and Aug. 18, bringing the total number of shares owned by the fund to 4.355 million The stock climbed 16.24% to $3.15 in after-hours trading.
   Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update  2020/07/28 20:05:00 GlobeNewswire
Webcast and Conference Call to be Held at 5 p.m. EDT on August 4, 2020
   The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results  2020/07/23 12:25:53 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioLife Solutions Inc (NASDAQ: BLFS ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunic Inc (NASDAQ: IMUX ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) ( reported forecast-beating second-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Novo Nordisk A/S (NYSE: NVO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Otonomy Inc (NASDAQ: OTIC ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 22) Akouos Inc (NASDAQ: AKUS ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Forma Therapeutics Holdings Inc (NASDAQ: FMTX ) Fusion Pharmaceuticals Inc (NASDAQ: FUSN ) Gritstone Oncology Inc (NASDAQ: GRTS ) Nkarta Inc (NASDAQ: NKTX ) RENALYTIX AI ADR (NASDAQ: RNLX ) (went public Friday) Tricida Inc (NASDAQ: TCDA ) Stocks In Focus Midatech Terminates Sale Process, Strategic Review to Continue Midatech Pharma PLC-ADR (NASDAQ: MTP ), a drug delivery technology company, said it has terminated the formal sale process initiated in late April after it failed to receive any proposals from third parties.

calendar